GSK3B and prostate carcinoma: ✓an inhibitor of GSK3β (IC50 = 104 nM) [222]✓reduces p-RPS6 by inactivating S6K1 in breast cancer cells, colon cancer, kidney cells, osteosarcoma cells, and prostate cancer cells [83]